Dahili, Annie P.

HRN: 02-91-89  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/11/2025
CEFUROXIME 750MG (VIAL)
03/11/2025
03/18/2025
IV
750mg
Q8
UTI
Rejected 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Non-compliant To Guidelines